Biomark Diagnostics (Biomark Diagnostics) Total Assets : $1.01 Mil (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is Biomark Diagnostics Total Assets?

Biomark Diagnostics's Total Assets for the quarter that ended in Dec. 2023 was $1.01 Mil.

During the past 12 months, Biomark Diagnostics's average Total Assets Growth Rate was 37.90% per year. During the past 3 years, the average Total Assets Growth Rate was 197.80% per year. During the past 5 years, the average Total Assets Growth Rate was 155.80% per year.

During the past 10 years, Biomark Diagnostics's highest 3-Year average Total Assets Growth Rate was 317.20%. The lowest was -23.90%. And the median was 36.90%.

Total Assets is connected with ROA %. Biomark Diagnostics's annualized ROA % for the quarter that ended in Dec. 2023 was -164.56%. Total Assets is also linked to Revenue through Asset Turnover. Biomark Diagnostics's Asset Turnover for the quarter that ended in Dec. 2023 was 0.04.

Biomark Diagnostics Total Assets Historical Data

The historical data trend for Biomark Diagnostics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomark Diagnostics Total Assets Chart

Biomark Diagnostics Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Assets

Get a 7-Day Free Trial

0.03

0.46

0.76

1.16

0.54

Biomark Diagnostics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															0.65	0.54	0.54	0.47	1.01

Biomark Diagnostics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Biomark Diagnostics's Total Assets for the fiscal year that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (A: Mar. 2023 )	+	Total Liabilities (A: Mar. 2023 )
	=	-0.84	+	1.375
	=	0.54

Biomark Diagnostics's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	-0.417	+	1.423
	=	1.01

Biomark Diagnostics (OTCPK:BMKDF) Total Assets Explanation

Total Assets is connected with ROA %.

Biomark Diagnostics's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-1.212	/	( (0.467	+	1.006)	/ 2 )
	=	-1.212	/	0.7365
	=	-164.56 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Biomark Diagnostics's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0.031	/	( (0.467	+	1.006)	/ 2 )
=	0.031	/	0.7365
=	0.04

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Biomark Diagnostics Total Assets Related Terms

Thank you for viewing the detailed overview of Biomark Diagnostics's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomark Diagnostics (Biomark Diagnostics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomark Diagnostics Inc (OTCPK:BMKDF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

BUX:Canada

Address

130 - 3851 Shell Road, Richmond, BC, CAN, V6X 2W2

Website

https://www.biomarkdiagnostics.com

Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early treatment for cancer. Its research and development are focused on the role that metabolomics plays in early cancer detection. It is currently focused on bringing its liquid biopsy-based cancer diagnostic tests and detection solution to commercialization.

Biomark Diagnostics (Biomark Diagnostics) Headlines

No Headlines